Alligator Bioscience AB Cash Flow-to-Debt Ratio
Alligator Bioscience AB cash flow-to-debt ratio. Alligator Bioscience AB (ATORX) has a Cash Flow-to-Debt Ratio of -0.23x as of June 2026, meaning its operating cash flow of Skr-13.99 Million could theoretically repay 0% of its total liabilities (Skr61.79 Million) in one year. Check Alligator Bioscience AB cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Alligator Bioscience AB (2011–2025)
Cash flow-to-debt ratio of Alligator Bioscience AB from 2011 to 2025. Historical debt coverage capacity for Alligator Bioscience AB across 13 annual periods. Check ATORX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Alligator Bioscience AB Cash Flow-to-Debt Ratio by Year (2011–2025)
Alligator Bioscience AB cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Alligator Bioscience AB. For the full cash flow conversion analysis, see cash efficiency ratio of Alligator Bioscience AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.50x | Skr-155.99 Million | Skr103.74 Million | ▼ -66.3% |
| 2024 | -0.90x | Skr-212.43 Million | Skr234.93 Million | ▲ +49.1% |
| 2023 | -1.78x | Skr-189.28 Million | Skr106.59 Million | ▲ +17.1% |
| 2022 | -2.14x | Skr-172.61 Million | Skr80.53 Million | ▲ +14.1% |
| 2021 | -2.49x | Skr-127.03 Million | Skr50.93 Million | ▲ +35.2% |
| 2020 | -3.85x | Skr-141.35 Million | Skr36.69 Million | ▼ -13.3% |
| 2019 | -3.40x | Skr-178.96 Million | Skr52.63 Million | ▼ -30.1% |
| 2018 | -2.61x | Skr-104.11 Million | Skr39.85 Million | ▲ +34.2% |
| 2017 | -3.97x | Skr-99.63 Million | Skr25.08 Million | ▼ -159.8% |
| 2016 | -1.53x | Skr-37.61 Million | Skr24.59 Million | ▼ -114.4% |
| 2015 | 10.62x | Skr204.89 Million | Skr19.29 Million | ▲ +595.7% |
| 2014 | -2.14x | Skr-62.74 Million | Skr29.27 Million | ▲ +43.8% |
| 2011 | -3.82x | Skr-34.77 Million | Skr9.11 Million | — |